BriaCell Therapeutics Cor...

NASDAQ: BCTX · Real-Time Price · USD
0.74
0.00 (0.14%)
At close: Aug 15, 2025, 3:59 PM
0.72
-2.70%
After-hours: Aug 15, 2025, 07:39 PM EDT

BriaCell Therapeutics Income Statement

Financials in USD. Fiscal year is August - July.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jul 31, 2024 Jul 31, 2023 Jul 31, 2022 Jul 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
82.58K 20.49K 19.39K 19.44K
Gross Profit
-82.58K -20.49K -19.39K -19.44K
Operating Income
-32.81M -23.27M -15.29M 3.69M
Interest Income
283.51K 891.21K 136.73K 3.15K
Pretax Income
-4.85M -20.3M -26.84M -17.24K
Net Income
-4.72M -20.3M -11.58M -2.89M
Selling & General & Admin
9.18K 7.94M 7.27M 6.18K
Research & Development
26.75M 15.34M 10.27K 2.02M
Other Expenses
5.96M -763 -396 -0.00
Operating Expenses
32.73M 23.27M -3.39K -3.69M
Interest Expense
n/a n/a 979.00 46.09K
Selling & Marketing Expenses
686.00 n/a n/a n/a
Cost & Expenses
32.81M 23.27M 15.29M -3.69M
Income Tax Expense
n/a -153K 30.73K 6.58M
Shares Outstanding (Basic)
1.1K 1.04K 1.03K 301.00
Shares Outstanding (Diluted)
1.1K 1.04K 1.03K 301.31
EPS (Basic)
-6.03 -25.71 -33.27 -57.23
EPS (Diluted)
-6.03 -25.71 -33.27 -57.23
EBITDA
-4.77M -22.37M -34.05M -6.95M
EBIT
-4.85M -27.24M -34.07M -8.71K
Depreciation & Amortization
82.58K 15.27K 15.27K 15.26K